{
    "2018-08-24": [
        [
            {
                "time": "2018-01-05",
                "original_text": "Noteworthy Friday Option Activity: JNJ, USB, VLO",
                "features": {
                    "keywords": [
                        "Option Activity",
                        "JNJ",
                        "USB",
                        "VLO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-15",
                "original_text": "Top Research Reports for Johnson & Johnson, NIKE & BP",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Johnson & Johnson",
                        "NIKE",
                        "BP"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-10",
                "original_text": "3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?",
                "features": {
                    "keywords": [
                        "Drug Stocks",
                        "Cash Stockpiles",
                        "Investment Advice"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-20",
                "original_text": "TransEnterix Expected to Report Solid Rise in Revenues in 2018",
                "features": {
                    "keywords": [
                        "TransEnterix",
                        "Revenue Growth",
                        "2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-27",
                "original_text": "Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018",
                "features": {
                    "keywords": [
                        "Ex-Dividend Date",
                        "JNJ"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "An Overview of Roche’s Hemato-Oncology Drugs MabThera and Gazvya",
                "features": {
                    "keywords": [
                        "Roche",
                        "Hemato-Oncology",
                        "Drugs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-05",
                "original_text": "What Analysts Recommend for TransEnterix and Peers in August 2018",
                "features": {
                    "keywords": [
                        "Analysts Recommendations",
                        "TransEnterix",
                        "Peers"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-15",
                "original_text": "What Does Stryker’s Valuation Trend Indicate?",
                "features": {
                    "keywords": [
                        "Stryker",
                        "Valuation Trend"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}